NCT01221441View on ClinicalTrials.gov

Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2014

Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL

TissueGene-C

Single intraarticular injection at 3 x 10e7 cells

DRUG

Normal Saline

Single intraarticular injection of normal saline as a placebo control

Trial Locations (5)

16801

University Orthopedics, State College

19107

Rothman Institute, Philadelphia

21215

Sinai Hospital of Baltimore, Baltimore

22205

Commonwealth Orthopedics, Arlington

33781

Advent Clinical Research, Pinellas Park

Sponsors
All Listed Sponsors
lead

Kolon TissueGene, Inc.

INDUSTRY